Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 10,865 | 10,561 | 9,019 | 7,449 | 9,625 |
| Cost of Goods | 2,400 | 4,900 | 4,250 | 3,690 | 4,480 |
| Gross Profit | 8,450 | 5,680 | 4,760 | 3,750 | 5,140 |
| Operating Expenses | 13,740 | 14,640 | 14,270 | 18,440 | 15,140 |
| Operating Income | -4,875 | -8,079 | -9,251 | -13,991 | -9,515 |
| Interest Expense | 0 | 10 | 0 | 0 | 0 |
| Other Income | 285 | 389 | 191 | 391 | 445 |
| Pre-tax Income | -4,590 | -7,700 | -9,060 | -13,600 | -9,070 |
| Income Tax | -900 | -1,750 | 40 | 30 | -10 |
| Net Income Continuous | -3,696 | -5,445 | -9,106 | -13,633 | -9,061 |
| Net Income | $-3,696 | $-5,445 | $-9,106 | $-13,633 | $-9,061 |
| EPS Basic Total Ops | -0.15 | -0.23 | -0.38 | -0.57 | -0.38 |
| EPS Basic Continuous Ops | -0.15 | -0.23 | -0.38 | -0.57 | -0.38 |
| EPS Diluted Total Ops | -0.15 | -0.23 | -0.38 | -0.57 | -0.38 |
| EPS Diluted Continuous Ops | -0.15 | -0.23 | -0.38 | -0.57 | -0.38 |
| EBITDA(a) | $-3,235 | $-6,419 | $-7,721 | $-12,461 | $-8,045 |